- Business Wire•3 days ago
InVivo Therapeutics Holdings Corp. today announced that a new patient has been enrolled into The INSPIRE Study .
- Business Wire•4 days ago
InVivo Therapeutics Holdings Corp. today announced that Mark Perrin was interviewed by Lisa Davis, M.P.H., C.N.C. for a segment on “It’s Your Health” radio during the annual J.P.
- Business Wire•5 days ago
InVivo Therapeutics Holdings Corp. today announced that the University of New Mexico Hospital in Albuquerque, NM has been added as a clinical site for The INSPIRE Study: InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold™ for Safety and Neurologic Recovery in Subjects with Complete Thoracic AIS A Spinal Cord Injury.
NVIV : Summary for InVivo Therapeutics Holdings Co - Yahoo Finance
InVivo Therapeutics Holdings Corp. (NVIV)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Day's Range||4.35 - 4.43|
|52 Week Range||3.50 - 10.36|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-5.71|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|